Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: In his Commentary, Dr Gostin1 expresses concern that the current regulation of marijuana is flawed. He states that the Controlled Substances Act does not adequately address the potential medical benefit that the use of marijuana can provide, citing data from the Institute of Medicine that tetrahydrocannabinol (THC) may be useful in the treatment of pain, nausea, vomiting, and appetite suppression. He states that the present regulation of marijuana inappropriately interferes with the patient-physician relationship by punishing physicians who prescribe marijuana to relieve pain and suffering; this impedes the physician's ability to speak frankly and openly with patients regarding potential treatment options.
Das R. Regulation of Medical Marijuana. JAMA. 2005;294(24):3091–3092. doi:10.1001/jama.294.24.3091-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: